Antibody tests have higher sensitivity at ≥15 days after symptom onset and 99% specificity for detecting SARS-CoV-2.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

1. Towards a comprehensive view of the herpes B virus.Frontiers in immunology · 2023
   Review
2. Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum.Journal of clinical microbiology · 2021
   Article
3. Serological Tests in the Detection of SARS-CoV-2 Antibodies.Diagnostics (Basel, Switzerland) · 2021
   Article

Corrections and comments

• Comment on
  Antibody tests for identification of current and past infection with SARS-CoV-2.2020

Authors and funding

2 authors at 1 institution in 1 country.

Funding

Abstract

Indexed as